MX2011011959A - Emulsion aceite en agua de mometasona y propilenglicol. - Google Patents

Emulsion aceite en agua de mometasona y propilenglicol.

Info

Publication number
MX2011011959A
MX2011011959A MX2011011959A MX2011011959A MX2011011959A MX 2011011959 A MX2011011959 A MX 2011011959A MX 2011011959 A MX2011011959 A MX 2011011959A MX 2011011959 A MX2011011959 A MX 2011011959A MX 2011011959 A MX2011011959 A MX 2011011959A
Authority
MX
Mexico
Prior art keywords
oil
mometasone
propylene glycol
water emulsion
water
Prior art date
Application number
MX2011011959A
Other languages
English (en)
Other versions
MX345888B (es
Inventor
Henri Hansson
Anna Karin Moren
Original Assignee
Galenica Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Galenica Ab filed Critical Galenica Ab
Publication of MX2011011959A publication Critical patent/MX2011011959A/es
Publication of MX345888B publication Critical patent/MX345888B/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/04—Antipruritics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Dermatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dispersion Chemistry (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Steroid Compounds (AREA)

Abstract

Se describen las nuevas composiciones farmacéuticas de mometasona o un derivado farmacéuticamente aceptable de la misma, en la forma de una emulsión aceite en agua, principalmente una crema. La composición tiene una excelente estabilidad y efecto terapéutico. Las composiciones contienen mometasona en forma micronizada, propilenglicol y agua y la proporción en peso entre el propilenglicol y el agua contenida en la emulsión aceite en agua es de 1:1 a aproximadamente 1:3.
MX2011011959A 2009-05-12 2010-05-12 Emulsion aceite en agua de mometasona y propilenglicol. MX345888B (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DKPA200900601 2009-05-12
PCT/EP2010/002921 WO2010130428A1 (en) 2009-05-12 2010-05-12 Oil-in-water emulsion of mometasone and propylene glycol

Publications (2)

Publication Number Publication Date
MX2011011959A true MX2011011959A (es) 2012-05-08
MX345888B MX345888B (es) 2017-02-22

Family

ID=42352732

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2011011959A MX345888B (es) 2009-05-12 2010-05-12 Emulsion aceite en agua de mometasona y propilenglicol.

Country Status (20)

Country Link
US (2) US8728497B2 (es)
EP (2) EP2429510B1 (es)
JP (2) JP5833541B2 (es)
CN (1) CN102458382B (es)
AU (1) AU2010246613B2 (es)
BR (1) BRPI1010907B8 (es)
CA (1) CA2761739C (es)
CY (1) CY1116667T1 (es)
DK (1) DK2429510T3 (es)
ES (2) ES2813400T3 (es)
HR (1) HRP20150959T1 (es)
HU (1) HUE027718T2 (es)
MX (1) MX345888B (es)
NZ (1) NZ596429A (es)
PL (2) PL2429510T3 (es)
PT (1) PT2429510E (es)
RU (1) RU2526911C2 (es)
SI (1) SI2429510T1 (es)
SM (1) SMT201500297B (es)
WO (1) WO2010130428A1 (es)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HUE027718T2 (en) 2009-05-12 2016-10-28 Galenica Ab Oil-in-water emulsion containing mometasone and propylene glycol
PT105982B (pt) * 2011-11-03 2014-07-29 Laboratório Edol Produtos Farmac Uticos S A Composição e método de preparação a frio de uma emulsão utilizada como veículo de fármacos anti-inflamatórios
JP7262227B2 (ja) * 2017-10-23 2023-04-21 マルホ株式会社 被膜形成外用剤
WO2019182969A1 (en) * 2018-03-19 2019-09-26 Essential Lipid Technologies, LLC Topical phospholipid formulations and methods for preparing the same

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4282216A (en) * 1977-04-20 1981-08-04 Johnson & Johnson Topical anti-inflammatory drug therapy
US4808610A (en) * 1986-10-02 1989-02-28 Schering Corporation Mometasone furoate anti-inflammatory cream composition using hexylene glycol
AU6974191A (en) * 1989-12-20 1991-07-18 Schering Corporation Stable cream and lotion bases for lipophilic drug compositions
US6127353A (en) 1991-09-06 2000-10-03 Schering Corporation Mometasone furoate monohydrate, process for making same and pharmaceutical compositions
WO1994013257A1 (en) * 1992-12-16 1994-06-23 Creative Products Resource Associates, Ltd. Occlusive/semi-occlusive lotion for treatment of a skin disease or disorder
US5696105A (en) * 1996-03-14 1997-12-09 Hackler; Walter A. Antifungal nail composition
US5952003A (en) * 1996-08-01 1999-09-14 Novartis Corporation Terazosin capsules
US6075056A (en) 1997-10-03 2000-06-13 Penederm, Inc. Antifungal/steroid topical compositions
US6720001B2 (en) * 1999-10-18 2004-04-13 Lipocine, Inc. Emulsion compositions for polyfunctional active ingredients
US7030203B2 (en) * 2001-09-28 2006-04-18 3M Innovative Properties Company Water-in-oil emulsions with ethylene oxide groups, compositions, and methods
PE20030828A1 (es) * 2002-03-04 2003-11-04 Novartis Ag Composicion oftalmica que comprende ascomicina
TR200201343A2 (tr) * 2002-05-17 2003-12-22 Orva İlaç Sanayi̇ Ve Ti̇caret A. Ş. Kortikosteroid ve antiseptik içeren farmasötik bileşim
DK1542904T3 (da) 2002-08-27 2008-04-21 Schering Corp Fremgangsmåde til fremstilling af formuleringer til en inhalator med målte doser
US10117812B2 (en) 2002-10-25 2018-11-06 Foamix Pharmaceuticals Ltd. Foamable composition combining a polar solvent and a hydrophobic carrier
US20060104968A1 (en) * 2003-03-05 2006-05-18 Halozyme, Inc. Soluble glycosaminoglycanases and methods of preparing and using soluble glycosaminogly ycanases
WO2004105686A2 (en) * 2003-05-23 2004-12-09 Taro Pharmaceuticals U.S.A., Inc. Novel topical steroid cream formulations
JP2007500231A (ja) 2003-05-23 2007-01-11 コンビナトアールエックス インコーポレーティッド 新生物を治療するための併用治療
US20050196462A1 (en) * 2003-12-30 2005-09-08 Oculus Innovative Sciences, Inc. Topical formulation containing oxidative reductive potential water solution and method for using same
US20070099883A1 (en) * 2005-10-07 2007-05-03 Cheryl Lynn Calis Anhydrous mometasone furoate formulation
DE102006034883A1 (de) * 2006-07-25 2008-01-31 Hermal Kurt Herrmann Gmbh & Co. Ohg Pharmazeutische Zusammensetzung enthaltend Mometasonfuroat
WO2008126076A2 (en) 2007-04-11 2008-10-23 Perrigo Israel Pharmaceuticals Ltd. Low-dose mometasone formulations
HUE027718T2 (en) 2009-05-12 2016-10-28 Galenica Ab Oil-in-water emulsion containing mometasone and propylene glycol
DK2429490T3 (en) 2009-05-12 2017-02-20 Galenica Ab OIL-IN-WATER EMULSION OF MOMETASON

Also Published As

Publication number Publication date
JP2012526738A (ja) 2012-11-01
CA2761739A1 (en) 2010-11-18
WO2010130428A1 (en) 2010-11-18
PL2429510T3 (pl) 2015-12-31
JP2015227354A (ja) 2015-12-17
PL2962688T3 (pl) 2020-11-02
CN102458382A (zh) 2012-05-16
RU2526911C2 (ru) 2014-08-27
RU2011150246A (ru) 2013-06-20
MX345888B (es) 2017-02-22
HUE027718T2 (en) 2016-10-28
EP2429510A1 (en) 2012-03-21
DK2429510T3 (en) 2015-09-28
US20140242171A1 (en) 2014-08-28
CA2761739C (en) 2017-03-07
NZ596429A (en) 2013-08-30
EP2962688B1 (en) 2020-06-24
US11395827B2 (en) 2022-07-26
AU2010246613B2 (en) 2014-07-17
ES2813400T3 (es) 2021-03-23
ES2547556T3 (es) 2015-10-07
BRPI1010907B1 (pt) 2020-10-20
BRPI1010907B8 (pt) 2021-05-25
BRPI1010907A2 (pt) 2016-03-15
CY1116667T1 (el) 2017-03-15
US8728497B2 (en) 2014-05-20
SI2429510T1 (sl) 2015-10-30
CN102458382B (zh) 2015-03-18
EP2962688A1 (en) 2016-01-06
PT2429510E (pt) 2015-10-12
EP2429510B1 (en) 2015-06-24
US20120171252A1 (en) 2012-07-05
SMT201500297B (it) 2016-01-08
HRP20150959T1 (hr) 2015-11-06
JP5833541B2 (ja) 2015-12-16
AU2010246613A1 (en) 2011-12-08

Similar Documents

Publication Publication Date Title
MX2021006035A (es) Formulaciones cannabinoides estables.
EP3329965A3 (en) Dosing regimen of anti-alpha4beta7-antikörper
WO2012079092A3 (en) Testosterone undecanoate compositions
NZ723838A (en) Cannabinoid compositions and uses
WO2012098562A3 (en) Liquid oral compositions of lanthanum salts
BR112013022495A2 (pt) formulação farmacêutica aquosa de tapentadol para administração oral
EP3626253A3 (en) Stable formulations of linaclotide
WO2012075081A3 (en) High-strength testosterone undecanoate compositions
MX2010002392A (es) Composiciones de brimonidina mejoradas para tratar eritema.
WO2012154679A8 (en) Tricyclic pyrazole sulfonamide compounds and methods of making and using same
EA201291108A1 (ru) Фармацевтические композиции в виде эмульсии с низким содержанием масла, содержащие прогестоген
WO2012035480A3 (en) Pharmaceutical compositions of curcumin
UA105766C2 (uk) Фармацевтична композиція, яка містить сіль стронцію, вітамін d і циклодекстрин
EA201300539A1 (ru) Твердая композиция для приема внутрь (варианты), способ терапевтической или нетерапевтической профилактики желудочно-кишечных расстройств или поддержания здорового состояния желудочно-кишечного тракта с ее помощью (варианты) и упаковка, ее содержащая
WO2013183062A3 (en) Palatable formulations of ibuprofen
WO2015033302A3 (en) Fulvestrant compositions
MX2017013244A (es) Dentifricos a base de calcio para una mejor absorcion de los ingredientes activos.
MX2011011959A (es) Emulsion aceite en agua de mometasona y propilenglicol.
UA75461U (uk) Засіб для профілактики стоматологічних захворювань
WO2014178789A9 (en) Topical composition and carrier for administration of pharmaceutically or cosmetically active ingredients
WO2011093815A3 (en) Pharmaceutical compositions comprising formoterol and mometasone
MX2012013642A (es) Composiciones farmaceuticas topicas que comprenden furoato de mometasona.
BR112015001627A2 (pt) composição farmacêutica, respectivos usos e método para diminuir a frequência de micção
WO2016195194A3 (ko) 신규한 tlr2 길항제
WO2011119649A3 (en) Pharmaceutical compositions containing berberine for treatment or prevention of weight gain and obesity associated with anti-psychotic drugs

Legal Events

Date Code Title Description
FG Grant or registration